Objectives This study aimed to identify the resistance mechanisms to micafungin and
fluconazole in a clinical isolate of Candida glabrata. Methods The isolate was whole …

The opportunistic pathogen Candida parapsilosis is a major causative agent of candidiasis
leading to death in immunocompromised individuals. Azoles are the first line of defense in …

Chronic disseminated candidiasis (CDC) is a rare complication of immunosuppression. This
review describes the presentation, management, and outcomes of CDC in pediatric patients …

Antimicrobial resistance is a serious threat, particularly in low-and middle-income countries
(LMICs). Antifungal resistance is often underestimated in both healthcare and non-clinical …

Abstract Background The prevalence of Candida glabrata healthcare‐associated infections
is on the rise worldwide and in Lebanon, Candida glabrata infections are difficult to treat as …

Candida glabrata exhibits innate resistance to azole antifungal drugs but also has the
propensity to rapidly develop clinical drug resistance. Azole drugs, which target Erg11, is …

Most bacteria and fungi are capable of producing biofilms, enabling them to thrive in nature
on distinct surfaces. Biofilm formation stands out as one of the most prominent virulence …

Acquired resistance in Candida albicans brings about a serious challenge to the clinical
application of azoles, so it is urgent to elucidate the mechanisms of azole resistance to …

Background The incidence of nosocomial candidemia has increased in recently years,
however, the epidemiological data remain insufficient in China. Methods A total of 234 …

Candida glabrata exhibits innate resistance to azole antifungal drugs but also has the
propensity to rapidly develop clinical drug resistance. Azole drugs, which target Erg11, is …